S&P 500 7,410.50 ▲ 45.04 (+0.61%) DOW 52,127.58 ▲ 460.74 (+0.89%) NASDAQ 25,757.21 ▲ 170.17 (+0.67%) US Markets Open â€ĸ 12:04 PM ET

GWLL

Goldenwell Biotech, Inc.

Price Chart
Latest Quote

$0.52

+0.00 (+0.00%)
Current Price
Previous Close $0.52
Open $0.52
Day High $0.52
Day Low $0.52
Volume 984
Fetched: 2026-06-24T16:04:48
Stock Information
Shares Outstanding 99.00M
Total Debt $276K
Cash Equivalents $46K
Revenue $62K
Net Income $-75K
Sector Consumer Defensive
Industry Packaged Foods
Market Cap $51.48M
Exchange PNK
📊 Comprehensive Analysis
Company Data
Enterprise Value$51.71M
Sales$62K
Income$-75K
Book/sh$-0.00
Cash/sh$0.00
Financial Ratios
Quick Ratio1.16
Current Ratio5.60
Returns & Margins
ROA-20.20%
Gross Margin100.12%
Operating Margin-23.54%
Profit Margin-120.49%
Ownership
Insider Ownership63.64%
Insider & Institutional transactions data not available
Valuation Ratios
P/S825.77
P/B-520.00
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.61
SMA50$0.77
SMA200$1.44
RSInan
Shares Float36.00M
Volatility4.29
Performance History
Week+0.00%
Month+1.96%
Quarter-48.18%
6 Months-82.67%
YTD-82.07%
Year+160.00%
3 Years+76.27%
10 Years+76.27%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-23 $0.52 0
2026-06-22 $0.52 0
2026-06-18 $0.52 0
2026-06-17 $0.52 0
2026-06-16 $0.52 0
2026-06-15 $0.52 0
2026-06-12 $0.52 0
2026-06-11 $0.52 0
2026-06-10 $0.52 0
2026-06-09 $0.52 0
2026-06-08 $0.52 0
2026-06-05 $0.52 0
2026-06-04 $0.52 0
2026-06-03 $0.52 1,250
2026-06-02 $0.52 0
2026-06-01 $0.52 169
2026-05-29 $0.90 0
2026-05-28 $0.90 1,000
2026-05-27 $1.00 0
2026-05-26 $1.00 0
About Goldenwell Biotech, Inc.

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.

📰 Latest News
No news articles available at the moment. Check back later for updates on GWLL.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $75 $1,170 $22,614 $7,579
Cost Of Revenue $75 $1,170 $22,614 $7,579
Total Revenue $139 $1,836 $47,800 $15,967
Operating Revenue $139 $1,836 $47,800 $15,967
Expenses
Total Expenses $123,237 $117,662 $1,032,905 $134,234
Other Income Expense $-8,400 $-1,535 $8 $1,286
Other Non Operating Income Expenses $-8,400 $-1,535 $8 $1,286
Operating Expense $123,162 $116,492 $1,010,291 $126,655
General And Administrative Expense $123,162 $116,492 $1,010,291 $126,655
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-131,498 $-117,361 $-985,097 $-116,981
Normalized Income $-131,498 $-117,361 $-985,097 $-116,981
Net Income From Continuing And Discontinued Operation $-131,498 $-117,361 $-985,097 $-116,981
Total Operating Income As Reported $-123,098 $-115,826 $-985,105 $-118,267
Net Income Common Stockholders $-131,498 $-117,361 $-985,097 $-116,981
Net Income $-131,498 $-117,361 $-985,097 $-116,981
Net Income Including Noncontrolling Interests $-131,498 $-117,361 $-985,097 $-116,981
Net Income Continuous Operations $-131,498 $-117,361 $-985,097 $-116,981
Pretax Income $-131,498 $-117,361 $-985,097 $-116,981
Operating Income $-123,098 $-115,826 $-985,105 $-118,267
Gross Profit $64 $666 $25,186 $8,388
Per Share
Diluted EPS $0.00 $0.00 $-0.01 $-0.00
Basic EPS $0.00 $0.00 $-0.01 $-0.00
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-123,098 $-115,826 $-985,105 $-118,267
EBITDA (Bullshit earnings) $-123,098 $-115,826 $-985,105 $-118,267
EBIT $-123,098 $-115,826 $-985,105 $-118,267
Diluted Average Shares $99,000,000 $99,000,000 $96,433,333 $91,322,222
Basic Average Shares $99,000,000 $99,000,000 $96,433,333 $91,322,222
Diluted NI Availto Com Stockholders $-131,498 $-117,361 $-985,097 $-116,981
Tax Provision $0 $0 - -
Selling General And Administration $123,162 $116,492 $1,010,291 $126,655
Other Gand A $123,162 $116,492 $1,010,291 $126,655
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-47,241 $84,257 $201,618 $301,714
Total Assets $224,192 $228,094 $248,400 $460,979
Total Non Current Assets $0 $0 $26,346 $48,752
Current Assets $224,192 $228,094 $222,054 $412,227
Inventory $174,788 $174,863 $176,058 $198,671
Cash Cash Equivalents And Short Term Investments $49,404 $53,231 $45,996 $213,556
Cash And Cash Equivalents $49,404 $53,231 $45,996 $213,556
Cash Financial $49,404 $53,231 $45,996 $213,556
Debt
Net Debt $46,184 $42,357 - -
Total Debt $95,588 $95,588 $25,372 $47,779
Long Term Debt And Capital Lease Obligation $95,588 $95,588 - $0
Long Term Debt $95,588 $95,588 - -
Current Debt And Capital Lease Obligation - - $25,372 $47,779
Liabilities
Total Liabilities Net Minority Interest $271,433 $143,837 $46,782 $159,265
Total Non Current Liabilities Net Minority Interest $269,573 $141,923 $20,000 $-2
Other Non Current Liabilities $173,985 $46,335 $20,000 $-2
Current Liabilities $1,860 $1,914 $26,782 $159,267
Current Deferred Liabilities $1,860 $1,914 $1,410 -
Other Current Liabilities - - - $-1
Payables And Accrued Expenses - - - $111,488
Payables - - - $111,488
Accounts Payable - - - $111,488
Equity
Common Stock Equity $-47,241 $84,257 $201,618 $301,714
Total Equity Gross Minority Interest $-47,241 $84,257 $201,618 $301,714
Stockholders Equity $-47,241 $84,257 $201,618 $301,714
Retained Earnings $-1,359,645 $-1,228,147 $-1,110,786 $-125,690
Other
Ordinary Shares Number $99,000,000 $99,000,000 $99,000,000 $96,000,000
Share Issued $99,000,000 $99,000,000 $99,000,000 $96,000,000
Tangible Book Value $-47,241 $84,257 $201,618 $301,714
Invested Capital $48,347 $179,845 $201,618 $301,714
Working Capital $222,332 $226,180 $195,272 $252,960
Total Capitalization $48,347 $179,845 $201,618 $301,714
Additional Paid In Capital $1,302,504 $1,302,504 $1,302,504 $417,804
Capital Stock $9,900 $9,900 $9,900 $9,600
Common Stock $9,900 $9,900 $9,900 $9,600
Current Deferred Revenue $1,860 $1,914 $1,410 -
Capital Lease Obligations - $0 $25,372 $47,779
Current Capital Lease Obligation - $0 $25,372 $47,779
Net PPE - $0 $26,346 $48,752
Gross PPE - $0 $26,346 $48,752
Other Properties - - $26,346 $48,752
Long Term Capital Lease Obligation - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-123,077 $-113,153 $-1,072,560 $-205,138
Operating Activities
Operating Cash Flow $-123,077 $-113,153 $-1,072,560 $-205,138
Cash Flow From Continuing Operating Activities $-123,077 $-113,153 $-1,072,563 $-205,138
Financing Activities
Financing Cash Flow $119,250 $120,388 $905,000 $170,125
Cash Flow From Continuing Financing Activities $119,250 $120,388 $905,000 $170,125
Net Other Financing Charges - $75,588 - $78,225
Issuance Of Capital Stock - - $885,000 $91,900
Net Common Stock Issuance - - $885,000 $91,900
Common Stock Issuance - - $885,000 $91,900
Other
Repayment Of Debt $0 $-25,200 - -
Issuance Of Debt $119,250 $70,000 $20,000 -
Interest Paid Supplemental Data $0 $0 - -
Income Tax Paid Supplemental Data $0 $0 - -
End Cash Position $49,404 $53,231 $45,996 $213,556
Beginning Cash Position $53,231 $45,996 $213,556 $248,569
Changes In Cash $-3,827 $7,235 $-167,560 $-35,013
Net Issuance Payments Of Debt $119,250 $44,800 $20,000 -
Net Long Term Debt Issuance $119,250 $44,800 $20,000 -
Long Term Debt Payments $0 $-25,200 - -
Long Term Debt Issuance $119,250 $70,000 $20,000 -
Change In Working Capital $21 $2,673 $-87,466 $-88,157
Change In Other Working Capital $-54 $504 $1,410 -
Change In Other Current Liabilities $0 $-25,372 $-22,407 $47,779
Change In Other Current Assets $0 $26,346 $22,406 $-48,753
Change In Inventory $75 $1,195 $22,613 $-198,671
Other Non Cash Items $8,400 $1,535 $3 $-1
Net Income From Continuing Operations $-131,498 $-117,361 $-985,097 $-116,981
Change In Payables And Accrued Expense - - $-111,488 $111,488
Change In Payable - - $-111,488 $111,488
Change In Account Payable - - $-111,488 $111,488
Change In Prepaid Assets - - - $0
Fetched: 2026-02-02